TY - JOUR AU - Fearon, K. AU - Strasser, F. AU - Anker, S. D. PY - 2011 DA - 2011// TI - Definition and classification of cancer cachexia: an international consensus JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(10)70218-7 DO - 10.1016/S1470-2045(10)70218-7 ID - Fearon2011 ER - TY - JOUR AU - Aniort, J. AU - Polge, C. AU - Claustre, A. PY - 2016 DA - 2016// TI - Upregulation of MuRF1 and MAFbx participates to muscle wasting upon gentamicin-induced acute kidney injury JO - Int J Biochem Cell Biol VL - 79 UR - https://doi.org/10.1016/j.biocel.2016.04.006 DO - 10.1016/j.biocel.2016.04.006 ID - Aniort2016 ER - TY - JOUR AU - Argiles, J. M. AU - Busquets, S. AU - Stemmler, B. PY - 2015 DA - 2015// TI - Cachexia and sarcopenia: mechanisms and potential targets for intervention JO - Curr Opin Pharmacol VL - 22 UR - https://doi.org/10.1016/j.coph.2015.04.003 DO - 10.1016/j.coph.2015.04.003 ID - Argiles2015 ER - TY - JOUR AU - Sacheck, J. M. AU - Hyatt, J. P. AU - Raffaello, A. PY - 2007 DA - 2007// TI - Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases JO - FASEB J VL - 21 UR - https://doi.org/10.1096/fj.06-6604com DO - 10.1096/fj.06-6604com ID - Sacheck2007 ER - TY - JOUR AU - Haehling, S. AU - Anker, S. D. PY - 2010 DA - 2010// TI - Cachexia as a major underestimated and unmet medical need: facts and numbers JO - J Cachexia Sarcopenia Muscle VL - 1 UR - https://doi.org/10.1007/s13539-010-0002-6 DO - 10.1007/s13539-010-0002-6 ID - Haehling2010 ER - TY - JOUR AU - Fearon, K. C. PY - 2011 DA - 2011// TI - Cancer cachexia and fat-muscle physiology JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMcibr1106880 DO - 10.1056/NEJMcibr1106880 ID - Fearon2011 ER - TY - JOUR AU - Ali, S. AU - Chen, J. A. AU - Garcia, J. M. PY - 2013 DA - 2013// TI - Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment JO - Curr Opin Support Palliat Care VL - 7 UR - https://doi.org/10.1097/SPC.0000000000000012 DO - 10.1097/SPC.0000000000000012 ID - Ali2013 ER - TY - JOUR AU - Schakman, O. AU - Gilson, H. AU - Kalista, S. PY - 2009 DA - 2009// TI - Mechanisms of muscle atrophy induced by glucocorticoids JO - Horm Res VL - 72 UR - https://doi.org/10.1159/000229762 DO - 10.1159/000229762 ID - Schakman2009 ER - TY - JOUR AU - Smith, K. L. AU - Tisdale, M. J. PY - 1993 DA - 1993// TI - Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia JO - Br J Cancer VL - 67 UR - https://doi.org/10.1038/bjc.1993.126 DO - 10.1038/bjc.1993.126 ID - Smith1993 ER - TY - JOUR AU - Han, H. Q. AU - Zhou, X. AU - Mitch, W. E. PY - 2013 DA - 2013// TI - Myostatin/activin pathway antagonism: molecular basis and therapeutic potential JO - Int J Biochem Cell Biol VL - 45 UR - https://doi.org/10.1016/j.biocel.2013.05.019 DO - 10.1016/j.biocel.2013.05.019 ID - Han2013 ER - TY - JOUR AU - Sandri, M. PY - 2016 DA - 2016// TI - Protein breakdown in cancer cachexia JO - Semin Cell Dev Biol VL - 54 UR - https://doi.org/10.1016/j.semcdb.2015.11.002 DO - 10.1016/j.semcdb.2015.11.002 ID - Sandri2016 ER - TY - JOUR AU - Johns, N. AU - Stephens, N. A. AU - Fearon, K. C. PY - 2013 DA - 2013// TI - Muscle wasting in cancer JO - Int J Biochem Cell Biol VL - 45 UR - https://doi.org/10.1016/j.biocel.2013.05.032 DO - 10.1016/j.biocel.2013.05.032 ID - Johns2013 ER - TY - JOUR AU - Mueller, T. C. AU - Bachmann, J. AU - Prokopchuk, O. PY - 2016 DA - 2016// TI - Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans? JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2121-8 DO - 10.1186/s12885-016-2121-8 ID - Mueller2016 ER - TY - JOUR AU - Costelli, P. AU - Muscaritoli, M. AU - Bossola, M. PY - 2006 DA - 2006// TI - IGF-1 is downregulated in experimental cancer cachexia JO - Am J Physiol Regul Integr Comp Physiol VL - 291 UR - https://doi.org/10.1152/ajpregu.00104.2006 DO - 10.1152/ajpregu.00104.2006 ID - Costelli2006 ER - TY - JOUR AU - Guttridge, D. C. PY - 2015 DA - 2015// TI - A TGF-beta pathway associated with cancer cachexia JO - Nat Med VL - 21 UR - https://doi.org/10.1038/nm.3988 DO - 10.1038/nm.3988 ID - Guttridge2015 ER - TY - JOUR AU - Roth, S. M. AU - Walsh, S. PY - 2004 DA - 2004// TI - Myostatin: a therapeutic target for skeletal muscle wasting JO - Curr Opin Clin Nutr Metab Care VL - 7 UR - https://doi.org/10.1097/00075197-200405000-00004 DO - 10.1097/00075197-200405000-00004 ID - Roth2004 ER - TY - JOUR AU - McPherron, A. C. AU - Lawler, A. M. AU - Lee, S. J. PY - 1997 DA - 1997// TI - Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member JO - Nature VL - 387 UR - https://doi.org/10.1038/387083a0 DO - 10.1038/387083a0 ID - McPherron1997 ER - TY - JOUR AU - Artaza, J. N. AU - Bhasin, S. AU - Mallidis, C. PY - 2002 DA - 2002// TI - Endogenous expression and localization of myostatin and its relation to myosin heavy chain distribution in C2C12 skeletal muscle cells JO - J Cell Physiol VL - 190 UR - https://doi.org/10.1002/jcp.10044 DO - 10.1002/jcp.10044 ID - Artaza2002 ER - TY - JOUR AU - Dutt, V. AU - Gupta, S. AU - Dabur, R. PY - 2015 DA - 2015// TI - Skeletal muscle atrophy: potential therapeutic agents and their mechanisms of action JO - Pharmacol Res VL - 99 UR - https://doi.org/10.1016/j.phrs.2015.05.010 DO - 10.1016/j.phrs.2015.05.010 ID - Dutt2015 ER - TY - JOUR AU - Gallot, Y. S. AU - Durieux, A. C. AU - Castells, J. PY - 2014 DA - 2014// TI - Myostatin gene inactivation prevents skeletal muscle wasting in cancer JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-14-0057 DO - 10.1158/0008-5472.CAN-14-0057 ID - Gallot2014 ER - TY - JOUR AU - Zhou, X. AU - Wang, J. L. AU - Lu, J. PY - 2010 DA - 2010// TI - Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival JO - Cell VL - 142 UR - https://doi.org/10.1016/j.cell.2010.07.011 DO - 10.1016/j.cell.2010.07.011 ID - Zhou2010 ER - TY - JOUR AU - Smith, R. C. AU - Lin, B. K. PY - 2013 DA - 2013// TI - Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders JO - Curr Opin Support Palliat Care VL - 7 UR - https://doi.org/10.1097/SPC.0000000000000013 DO - 10.1097/SPC.0000000000000013 ID - Smith2013 ER - TY - JOUR AU - Cash, J. N. AU - Angerman, E. B. AU - Kirby, R. J. PY - 2013 DA - 2013// TI - Development of a small-molecule screening method for inhibitors of cellular response to myostatin and activin A JO - J Biomol Screen VL - 18 UR - https://doi.org/10.1177/1087057113482585 DO - 10.1177/1087057113482585 ID - Cash2013 ER - TY - JOUR AU - Ge, M. AU - Liu, H. AU - Zhang, Y. PY - 2017 DA - 2017// TI - The anti-hepatic fibrosis effects of dihydrotanshinone I are mediated by disrupting the yes-associated protein and transcriptional enhancer factor D2 complex and stimulating autophagy JO - Br J Pharmacol VL - 174 UR - https://doi.org/10.1111/bph.13766 DO - 10.1111/bph.13766 ID - Ge2017 ER - TY - JOUR AU - Tan, B. H. AU - Birdsell, L. A. AU - Martin, L. PY - 2009 DA - 2009// TI - Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1525 DO - 10.1158/1078-0432.CCR-09-1525 ID - Tan2009 ER - TY - JOUR AU - Miller, B. S. AU - Ignatoski, K. M. AU - Daignault, S. PY - 2012 DA - 2012// TI - Worsening central sarcopenia and increasing intra-abdominal fat correlate with decreased survival in patients with adrenocortical carcinoma JO - World J Surg VL - 36 UR - https://doi.org/10.1007/s00268-012-1581-5 DO - 10.1007/s00268-012-1581-5 ID - Miller2012 ER - TY - JOUR AU - Rodriguez, J. AU - Vernus, B. AU - Chelh, I. PY - 2014 DA - 2014// TI - Myostatin and the skeletal muscle atrophy and hypertrophy signaling pathways JO - Cell Mol Life Sci VL - 71 UR - https://doi.org/10.1007/s00018-014-1689-x DO - 10.1007/s00018-014-1689-x ID - Rodriguez2014 ER - TY - JOUR AU - Smith, R. C. AU - Cramer, M. S. AU - Mitchell, P. J. PY - 2015 DA - 2015// TI - Myostatin neutralization results in preservation of muscle mass and strength in preclinical models of tumor-induced muscle wasting JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0681 DO - 10.1158/1535-7163.MCT-14-0681 ID - Smith2015 ER - TY - JOUR AU - Allen, D. L. AU - Unterman, T. G. PY - 2007 DA - 2007// TI - Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors JO - Am J Physiol Cell Physiol VL - 292 UR - https://doi.org/10.1152/ajpcell.00542.2005 DO - 10.1152/ajpcell.00542.2005 ID - Allen2007 ER - TY - JOUR AU - Budasz-Rwiderska, M. AU - Jank, M. AU - Motyl, T. PY - 2005 DA - 2005// TI - Transforming growth factor-beta1 upregulates myostatin expression in mouse C2C12 myoblasts JO - J Physiol Pharmacol VL - 56 ID - Budasz-Rwiderska2005 ER - TY - JOUR AU - Ma, K. AU - Mallidis, C. AU - Artaza, J. PY - 2001 DA - 2001// TI - Characterization of 5′-regulatory region of human myostatin gene: regulation by dexamethasone in vitro JO - Am J Physiol Endocrinol Metab VL - 281 UR - https://doi.org/10.1152/ajpendo.2001.281.6.E1128 DO - 10.1152/ajpendo.2001.281.6.E1128 ID - Ma2001 ER - TY - JOUR AU - Judge, S. M. AU - Wu, C. L. AU - Beharry, A. W. PY - 2014 DA - 2014// TI - Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-997 DO - 10.1186/1471-2407-14-997 ID - Judge2014 ER - TY - JOUR AU - Shan, T. AU - Liang, X. AU - Bi, P. PY - 2013 DA - 2013// TI - Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1alpha-Fndc5 pathway in muscle JO - FASEB J VL - 27 UR - https://doi.org/10.1096/fj.12-225755 DO - 10.1096/fj.12-225755 ID - Shan2013 ER - TY - JOUR AU - Hulmi, J. J. AU - Nissinen, T. A. AU - Rasanen, M. PY - 2018 DA - 2018// TI - Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle JO - J Cachexia Sarcopenia Muscle VL - 9 UR - https://doi.org/10.1002/jcsm.12265 DO - 10.1002/jcsm.12265 ID - Hulmi2018 ER - TY - JOUR AU - Nissinen, T. A. AU - Degerman, J. AU - Rasanen, M. PY - 2016 DA - 2016// TI - Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep32695 DO - 10.1038/srep32695 ID - Nissinen2016 ER - TY - JOUR AU - Kesik, V. AU - Honca, T. AU - Gulgun, M. PY - 2016 DA - 2016// TI - Myostatin as a marker for doxorubicin induced cardiac damage JO - Ann Clin Lab Sci VL - 46 ID - Kesik2016 ER - TY - JOUR AU - Seto, D. N. AU - Kandarian, S. C. AU - Jackman, R. W. PY - 2015 DA - 2015// TI - A key role for leukemia inhibitory factor in C26 cancer cachexia JO - J Biol Chem VL - 290 UR - https://doi.org/10.1074/jbc.M115.638411 DO - 10.1074/jbc.M115.638411 ID - Seto2015 ER - TY - JOUR AU - Golan, T. AU - Geva, R. AU - Richards, D. PY - 2018 DA - 2018// TI - LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial JO - J Cachexia Sarcopenia Muscle VL - 9 UR - https://doi.org/10.1002/jcsm.12331 DO - 10.1002/jcsm.12331 ID - Golan2018 ER - TY - JOUR AU - St Andre, M. AU - Johnson, M. AU - Bansal, P. N. PY - 2017 DA - 2017// TI - A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys JO - Skelet Muscle VL - 7 UR - https://doi.org/10.1186/s13395-017-0141-y DO - 10.1186/s13395-017-0141-y ID - St Andre2017 ER -